343787-29-1,MFCD11100329
Catalog No.:AA0035QM

343787-29-1 | Cp-673451

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
98%
in stock  
$17.00   $12.00
- +
5mg
98%
in stock  
$42.00   $30.00
- +
10mg
98%
in stock  
$63.00   $44.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0035QM
Chemical Name:
Cp-673451
CAS Number:
343787-29-1
Molecular Formula:
C24H27N5O2
Molecular Weight:
417.5035
MDL Number:
MFCD11100329
SMILES:
COCCOc1ccc2c(c1)ncn2c1ccc2c(n1)c(ccc2)N1CCC(CC1)N
Properties
Properties
 
Form:
Solid  
Storage:
Light sensitive;Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
572  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
31  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
3.3  

Downstream Synthesis Route

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

Literature

Title: Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.

Journal: Clinical & experimental metastasis 20080101

Title: Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

Journal: Cancer research 20050201

Title: Xi Y, et al. CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration. Onco Targets Ther. 2014 Jul 3;7:1215-21.

Title: Konotop G, et al. Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Res. 2016 Nov 15;76(22):6690-6700.

Title: Ehnman M, et al. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments. Cancer Res, 2013, 73(7), 2139-2149.

Title: Roberts WG, et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res, 2005, 65(3), 957-966.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:343787-29-1 Molecular Formula|343787-29-1 MDL|343787-29-1 SMILES|343787-29-1 Cp-673451
Catalog No.: AA0035QM
343787-29-1,MFCD11100329
343787-29-1 | Cp-673451
Pack Size: 1mg
Purity: 98%
in stock
$17.00 $12.00
Pack Size: 5mg
Purity: 98%
in stock
$42.00 $30.00
Pack Size: 10mg
Purity: 98%
in stock
$63.00 $44.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0035QM
Chemical Name: Cp-673451
CAS Number: 343787-29-1
Molecular Formula: C24H27N5O2
Molecular Weight: 417.5035
MDL Number: MFCD11100329
SMILES: COCCOc1ccc2c(c1)ncn2c1ccc2c(n1)c(ccc2)N1CCC(CC1)N
Properties
Form: Solid  
Storage: Light sensitive;Keep in dry area;2-8℃;  
Complexity: 572  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 31  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 1  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 3.3  
Downstream Synthesis Route
610-81-1    343787-29-1 

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

50982-75-7    343787-29-1 

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

343788-53-4    343787-29-1 

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

343788-55-6    343787-29-1 

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

343787-31-5    73874-95-0    343787-29-1 

[1]Effendi,Nurmaya;Ogawa,Kazuma;Mishiro,Kenji;Takarada,Takeshi;Yamada,Daisuke;Kitamura,Yoji;Shiba,Kazuhiro;Maeda,Takehiko;Odani,Akira[BioorganicandMedicinalChemistry,2017,vol.25,#20,p.5576-5585]

Literature fold

Title: Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.

Journal: Clinical & experimental metastasis20080101

Title: Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

Journal: Cancer research20050201

Title: Xi Y, et al. CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration. Onco Targets Ther. 2014 Jul 3;7:1215-21.

Title: Konotop G, et al. Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization. Cancer Res. 2016 Nov 15;76(22):6690-6700.

Title: Ehnman M, et al. Distinct effects of ligand-induced PDGFRα and PDGFRβ signaling in the human rhabdomyosarcoma tumor cell and stroma cell compartments. Cancer Res, 2013, 73(7), 2139-2149.

Title: Roberts WG, et al. Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451. Cancer Res, 2005, 65(3), 957-966.

Building Blocks More >
79200-56-9
79200-56-9
(1R)-(-)-2-Azabicyclo[2.2.1]hept-5-en-3-one
AA0035TZ | MFCD00211274
59483-54-4
59483-54-4
3-Chloro-2-nitroaniline
AA0035XB | MFCD01317803
33225-74-0
33225-74-0
2-nitroisonicotinic acid
AA00360B | MFCD04114160
35277-02-2
35277-02-2
4-Fluoro-1H-pyrazole
AA00363T | MFCD10699125
893620-44-5
893620-44-5
6-Bromo-5-fluoroindolin-2-one
AA003670 | MFCD16250437
864293-44-7
864293-44-7
2-Amino-5-bromo-3-methoxybenzoic acid
AA0036A5 | MFCD11101005
799293-85-9
799293-85-9
3-Bromothieno[3,2-c]pyridin-4-amine
AA0036D8 | MFCD08275115
7310-94-3
7310-94-3
2-Chloro-5-hydroxybenzaldehyde
AA0036GI | MFCD07783652
68716-49-4
68716-49-4
4-Bromophenylboronic acid, pinacol ester
AA0036JO | MFCD11110553
69-33-0
69-33-0
Tubercidin
AA0036N1 | MFCD00056012
Submit
© 2017 AA BLOCKS, INC. All rights reserved.